Clinical relevance of Elf-1 overexpression in endometrial carcinoma

By Takai N.   Miyazaki T.   Nishida M.   Shang S.   Nasu K.   Miyakawa I.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 408-413

Elsevier

Access to resources Recommend Favorite

MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus

By Popiolek D.   Yee H.   Levine P.   Vamvakas E.   Demopoulos R.I.  

Gynecologic Oncology, Vol. 90, Iss. 2, 2003-08 ,pp. : 353-357

Elsevier

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Expression Is Not Regulated by Estradiol or Medroxyprogesterone Acetate in Endometrial Carcinoma

By Kim Y.B.   Berek J.S.   Martinez-Maza O.   Satyaswaroop P.G.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 97-100

Academic Press

Access to resources Recommend Favorite

VEGF, flt-1, and KDR/flk-1 as Prognostic Indicators in Endometrial Carcinoma

By Fine B.A.   Valente P.T.   Feinstein G.I.   Dey T.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 33-39

Elsevier

Access to resources Recommend Favorite

Tumor-Associated Proteolytic Factors uPA and PAI-1 in Endometrial Carcinoma

By Kohler U.   Hiller K.   Martin R.   Langanke D.   Naumann G.   Bilek K.   Janicke F.   Schmitt M.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 268-274

Elsevier

Access to resources Recommend Favorite